DeHeng Advised Novoprotein on Obtaining Approval from SSE STAR Market IPO Committee

2022-04-29

On April 29, 2022, the application of Suzhou Novoprotein Scientific Co., Ltd. for initial public offering of A shares and listing on the STAR Market of Shanghai Stock Exchange was approved at the 34th session of the STAR Market IPO Committee in 2022. 

As the issuer's legal counsel, the DeHeng team was led by partners Zhang Lei, Wang Jianfeng and Li Zhenhui, with primary support from lawyers Zhu Yun, Li Haoyuan, Wu Qikai, Huang Pengshan, Zhang Jiyao and Zhou Lishan. They worked closely with the issuer, the sponsor Minsheng Securities and the audit firm RSM China (LLP), and provided comprehensive, professional, efficient and high-quality legal services for the client.